Market Overview

Benzinga's Top Upgrades

Share:
Related MRO
Nomura: It's Finally Time To Buy E&P Stocks
Morgan Stanley Is Upgrading Marathon Oil, But Why?
Related GLW
Barclays: Corning Still A 'Top Pick'
Corning Posts Upbeat Q1 Earnings, But Revenue Misses Estimates
Corning: A Buy As Post-Earnings Sell Off Is Unwarranted (Seeking Alpha)

Analysts at Credit Suisse upgraded Marathon Oil (NYSE: MRO) from “neutral” to “outperform.” Marathon Oil's shares closed at $30.31 yesterday. Marathon Oil's trailing-twelve-month revenue is $14.88 billion.

Analysts at Goldman upgraded Corning (NYSE: GLW) from “neutral” to “buy.” Corning's stock closed at $12.73 yesterday. Corning had $6.34 billion in total cash for the latest quarter.

Analysts at Wells Fargo upgraded St. Jude Medical (NYSE: STJ) from “market perform” to “outperform.” St. Jude Medical's shares closed at $42.90 yesterday. St. Jude Medical's PEG ratio is 1.34.

Analysts at Exane BNP Paribas upgraded AstraZeneca PLC (NYSE: AZN) from “underperform” to “neutral.” AstraZeneca's shares closed at $47.44 yesterday. AstraZeneca's trailing-twelve-month operating margin is 36.60%.

Latest Ratings for MRO

DateFirmActionFromTo
Apr 2015Deutsche BankMaintainsBuy
Apr 2015NomuraInitiates Coverage onBuy
Apr 2015Morgan StanleyUpgradesEqual-weightOverweight

View More Analyst Ratings for MRO
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (AZN + GLW)

Around the Web, We're Loving...